Journal: PLOS One
Article Title: Transport of CCL2 across an induced pluripotent stem cell-derived in vitro model of the human blood-brain barrier is heparan sulfate-dependent
doi: 10.1371/journal.pone.0338780
Figure Lengend Snippet: a. Representative immunocytochemistry of Heparan Sulfate clone F58-10E4 (HS(10E4)) (red) and DAPI (blue) in vehicle or HSase I, II, and III-treated iBECs. b-c. Immunofluorescence analysis of HS(10E4) mean fluorescence intensities (MFI) relative to DAPI area (b) or total HS(10E4) area relative to DAPI area (c). d-e. 125 I-CCL2 (d) or 131 I-Alb in the presence of 0.25 U/ml HSase I, II, and III compared to vehicle. f. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence of 0.25 U/ml HSase I, II, and III compared to vehicle. One differentiation was performed with n = 7-8 transwells per group. *p < 0.05, ***p < 0.001 (Unpaired two-tailed t-test). Means are displayed with their SD. Figure created with BioRender.
Article Snippet: The chloramine-T method was used to radioactively label recombinant carrier-free human CCL2 (R & D Systems, 279-MC-050/CF) with 125 I and bovine serum albumin (BSA, Sigma cat no. 17030-100G) with 131 I, as described previously [ ].
Techniques: Immunocytochemistry, Immunofluorescence, Fluorescence, Two Tailed Test